Appendix A.
Oral Prescription Medications.
| Disease | Medication Category |
|---|---|
| Antihyperlipidemic Agents | |
| Natural HMG CoA reductase inhibitors | |
| Niacin | |
| HMG CoA reductase inhibitor combination | |
| HMG CoA reductase inhibitors | |
| Bile acid sequestrants | |
| Fibric acid derivatives | |
| Antihyperlipidemics - misc | |
| Intestinal cholesterol absorption inhibitors | |
| Intest cholest absorp inhib-HMG CoA reductase inhib comb | |
| Nicotinic acid derivatives | |
| Asthma/COPD | |
| Beta adrenergics | |
| Adrenergic combinations | |
| Xanthines | |
| Bronchodilators - anticholinergics | |
| Nasal antihistamines | |
| Steroid inhalants | |
| Nasal steroids | |
| Steroid combinations | |
| Glucocorticosteroids | |
| Anti-inflammatory agents | |
| Nasal mast cell stabilizers | |
| Mineralocorticoids | |
| Mixed adrenergics | |
| Nasal anticholinergics | |
| Leukotriene receptor antagonists | |
| 5-lipoxygenase inhibitors | |
| Depression | |
| Trazodone HCL-dietary management product | |
| Tricyclic antidepressants | |
| Combination psychotherapeutics | |
| Antidepressants - misc. | |
| Antianxiety agents - misc. | |
| Benzodiazepines & tricyclic agents | |
| Selective serotonin reuptake inhibitors (SSRIs) | |
| Serotonin-norepinephrine reuptake inhibitors (SNRIs) | |
| Premenstrual dysphoric disorder (PMDD) agents - SSRIs | |
| Modified cyclics | |
| Thienbenzodiazepines & SSRIs | |
| Phenothiazines & tricyclic agents | |
| Diabetes | |
| Alpha-glucosidase inhibitors | |
| Sulfonylureas | |
| Incretin mimetic agents (GLP-1 receptor agonists) | |
| Sulfonylurea-biguanide combinations | |
| Biguanides | |
| Antidiabetic D-phenylalanine derivatives | |
| Thiazolidinediones | |
| Sulfonylurea-thiazolidinedione combinations | |
| Thiazolidinedione-biguanide combinations | |
| Meglitinide analogues | |
| Dipeptidyl peptidase-4 (DPP-4) inhibitors | |
| Dipeptidyl peptidase-4 (DPP-4) inhibitor-biguanide combinations | |
| Hypertension | |
| Beta blockers cardio-selective | |
| Alpha 1-adrenoceptor antagonists | |
| Direct renin inhibitors | |
| Direct renin inhibitors & thiazide/thiazide-like combinations | |
| Reserpine | |
| Diuretic combinations | |
| Potassium sparing diuretics | |
| Calcium channel blockers | |
| Ace inhibitor & calcium channel blocker combinations | |
| Angiotensin II receptor antag & CA channel blocker comb | |
| Beta blocker & diuretic combinations | |
| Ace inhibitors & thiazide/thiazide-like combinations | |
| Ace inhibitors | |
| Thiazides and thiazide-like diuretics | |
| Loop diuretics | |
| Angiotensin II receptor antagonists | |
| Angiotensin II receptor antagonists & thiazide combinations | |
| Beta blockers non-selective | |
| Alpha-beta blockers | |
| Adrenolytics-central & thiazide combinations | |
| Antiadrenergics - centrally acting | |
| Antiadrenergics - peripherally acting | |
| Selective aldosterone receptor antagonists (SARAs) | |
| Vasodilators & thiazide combinations | |
| Vasodilators | |
| Nitrate & vasodilator combinations | |
| Agents for pheochromocytoma | |
| Multiple Sclerosis | |
| Multiple sclerosis agents | |
| Multiple sclerosis agents - interferons | |
| Multiple sclerosis agents - monoclonal antibodies | |
| Oncology Agents | |
| Bisphosphonates | |
| Alkylating agents | |
| Aromatase inhibitors | |
| Antiandrogens | |
| Antineoplastic - multikinase inhibitors | |
| Nitrogen mustards | |
| Androgens | |
| Antineoplastic - tyrosine kinase inhibitors | |
| Estrogens-antineoplastic | |
| LHRH analogs | |
| Progestins | |
| Immunomodulators for myelodysplastic syndromes | |
| Selective estrogen receptor modulators (SERMs) | |
| Antiestrogens | |
| Imidazotetrazines | |
| Antileprotics | |
| Retinoids | |
| Osteoporosis | |
| Calcium combinations | |
| Calcium | |
| Vitamin D | |
| Antacids - calcium salts | |
| Parathyroid hormone and derivatives | |
| Bisphosphonates | |
| Calcitonins | |